The biological process of lysine-tRNA charging is therapeutically targetable in liver cancer.
Zhang R, Noordam L, Ou X, Ma B, Li Y, Das P, Shi S, Liu J, Wang L, Li P, Verstegen MMA, Reddy DS, van der Laan LJW, Peppelenbosch MP, Kwekkeboom J, Smits R, Pan Q.
Zhang R, et al. Among authors: peppelenbosch mp.
Liver Int. 2021 Jan;41(1):206-219. doi: 10.1111/liv.14692. Epub 2020 Oct 20.
Liver Int. 2021.
PMID: 33084231
Free PMC article.